| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,179,800 | 2,807,600 | 2,644,700 | 2,736,100 | | Cost of Revenue | 811,200 | 1,057,000 | 975,000 | 993,400 | | | Gross Profit | 1,368,600 | 1,750,600 | 1,669,700 | 1,742,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,200,200 | 1,378,500 | 1,372,600 | 1,368,800 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 168,400 | 372,100 | 297,100 | 373,900 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,100 | (12,400) | 6,700 | (3,400) | | Earnings Before Interest And Taxes | 171,500 | 359,700 | 303,800 | 370,500 | | Interest Expense | 24,800 | 23,600 | 24,600 | 26,100 | | Income Before Tax | 146,700 | 336,100 | 279,200 | 344,400 | | Income Tax Expense | 29,200 | 108,400 | 54,500 | 107,400 | | Minority Interest | (200) | 4,700 | (2,100) | (1,400) | | | | Net Income From Continuing Ops | 117,300 | 232,400 | 222,600 | 235,600 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 117,300 | 232,400 | 222,600 | 235,600 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $117,300 | $232,400 | $222,600 | $235,600 |
|
0.45% Nasdaq 
0.20%
Income Statement
